ライフサイエンスコーパス: dryness

1 oral therapies can ease the oral and ocular dryness.

2 B cell autoantibodies in mediating exocrine dryness.

3 warming rates depend inversely on ecosystem dryness.

4 sensitivity, and discomfort), and in 95% for dryness.

5 Hot flashes, night sweats, and vaginal dryness.

6 gas phase occurs upon solvent evaporation to dryness.

7 sal symptoms, such as hot flashes or vaginal dryness.

8 ic process of squamous metaplasia induced by dryness.

9 possible remedies, particularly for vaginal dryness.

10 ght junction protein occludin in response to dryness.

11 f 8 symptoms associated with oral and ocular dryness.

12 fold with varied degrees of film swelling or dryness.

13 symptoms of dry mouth, dry eyes, and overall dryness.

14 6% in the control group; P = 0.01) and nasal dryness (11.7% in the ipratropium group compared with 3.

15 small print (34%), medical costs (26%), and dryness (32%).

16 icity included grade 1 cheilitis (76%), skin dryness (43%), and elevated triglycerides (50%).

17 y and lacrimal, resulting in oral and ocular dryness, although virtually any organ system can be affe

18 Providing advice on treating vaginal dryness and brief sexual counseling can often alleviate

19 tween the frequency and evening intensity of dryness and discomfort and TBUT, Schirmer's tear test, o

20 Vaginal dryness and dyspareunia are significant estrogen-depleti

21 o appear to substantially ameliorate vaginal dryness and dyspareunia in breast cancer survivors.

22 tion, most patients complained about vaginal dryness and dyspareunia with impairment in sexual activi

23 to moderately decrease occurrence of vaginal dryness and dyspareunia.

24 mulation, and EDAR agonists may improve skin dryness and eczema frequently observed in XLHED.

25 on failure due to intensified growing season dryness and increased area burned would substantially de

26 Dryness and irritation symptoms, as opposed to a clinica

27 inician or "often" or "constant" symptoms of dryness and irritation.

28 Dryness and light sensitivity scales were then calculate

29 The survey included two symptom questions (dryness and light sensitivity) that inquired about frequ

30 when the reaction mixture was evaporated to dryness and redissolved in water.

31 he enriched phase obtained was evaporated to dryness and the residue reconstituted in 50muL of methan

32 The organic layer was evaporated to dryness and the residue was reconstituted in mobile phas

33 y in a range of conditions (pH, temperature, dryness) and was stable for a period of months.

34 e desire, 80% reported problems with vaginal dryness, and 62% reported pain or discomfort during pene

35 Ongoing treatment, vaginal dryness, and feeling unprepared for the impact of breast

36 for sexual problems at prediagnosis, vaginal dryness, and lower perceived sexual attractiveness were

37 usal symptoms including hot flashes, vaginal dryness, and sexual dysfunction.

38 , but only vasomotor dysfunction and vaginal dryness are consistently associated with this time of li

39 vious models have explained the low-latitude dryness as a result of atmospheric methane transport int

40 finitively identified increasing late-summer dryness as the cause.

41 eins are released via solvent evaporation to dryness, as envisioned by the charged residue model.

42 grast significantly improved symptoms of eye dryness, as measured by EDS, versus placebo in participa

43 charge than tamoxifen, but with more vaginal dryness, bone/muscle aches, and difficulty sleeping.

44 in the frequency of hot flashes and vaginal dryness but no significant reduction in night sweats.

45 st met the co-primary symptom end point (eye dryness) but not the co-primary sign end point (inferior

46 the mean (SD) numeric analog scale score for dryness changed from 6.38 (2.14) to 5.85 (2.57) in the p

47 proved symptoms of ocular discomfort and eye dryness compared with placebo when administered twice da

48 rea with T > 16 degrees C and now subject to dryness control rather than temperature as the regulator

49 This warming-induced extension of dryness-controlled areas may be triggering a positive fe

50 In areas now dryness-controlled, net carbon uptake is ~27% lower than

51 ture (e.g. warmer conditions increasing fuel dryness) could be counterbalanced by the indirect effect

52 ls is to evaporate droplets of the sample to dryness, creating solid deposits which are then Raman pr

53 During the first 4 weeks, average vaginal dryness decreased by 62% and 64% in the placebo and Repl

54 Frequencies of some side-effects (mouth dryness, decreased appetite, nausea, and constipation) w

55 ctivity on the ocular surface in response to dryness disrupts corneal epithelial barrier function.

56 III BC taking AIs with self-reported vaginal dryness, dyspareunia, or decreased libido were randomize

57 rvival to climate variation, with changes in dryness (either annual or during the growing season) exp

58 sexual health, several are mutable (vaginal dryness, emotional well-being, body image, the quality o

59 versible toxicities included skin and ocular dryness, fatigue, and mood changes.

60 to the high prevalence of vague symptoms of dryness, fatigue, and myalgias in the general population

61 on exemestane plus OFS reported more vaginal dryness, greater loss of sexual interest, and difficulti

62 spanic women reported urine leakage, vaginal dryness, heart pounding, and forgetfulness more (odds ra

63 distribution of women not reporting vaginal dryness in the past month improved significantly from 37

64 algia, myalgia, fatigue) and oral and ocular dryness in the presence of circulating antinuclear antib

65 treated T7-PKCdelta mice displayed excessive dryness in the skin of the tail with a variable penetran

66 MMP-9 concentration increased in response to dryness in wild-type mice.

67 sis requires objective signs and symptoms of dryness including a characteristic appearance of a biops

68 solvent impurities (e.g., trace benzophenone dryness indicator in THF) or, crucially, with allylic-CH

69 ents exhibited objective and subjective oral dryness, irrespective of etiology.

70 ects of CPAP and MADs included oral or nasal dryness, irritation, and pain, among others.

71 ious water-cycle parameters examined, global dryness is found to have the highest signal-to-noise rat

72 ration, volatilization due to overheating at dryness is minimized.

73 unctival epithelial response to experimental dryness is related to the degree of CD4+ T-cell infiltra

74 The timely diagnosis of oral dryness is vital for the management of orodental disease

75 iated with experiencing dyspareunia, vaginal dryness, low libido, and not experiencing orgasms after

76 onfidence interval [CI], 1.63-2.21), vaginal dryness (LR+ range, 1.48-3.79), high follicle-stimulatin

77 gions, explaining the low cloudiness and the dryness measured by the Galileo probe inside a hot spot.

78 y mild to moderate fatigue and mucocutaneous dryness, moderate to severe neutropenia (38%), and neutr

79 omen reported vasomotor symptoms and vaginal dryness more (odds ratios = 1.17-1.63) but urine leakage

80 ith SS or non-SS KCS reported discomfort and dryness most frequently and that many symptoms worsened

81 out the study for their global assessment of dryness (mouth, eyes, overall) as well as their subjecti

82 (four episodes), salivation (two episodes), dryness of mouth (two episodes), myoclonus like activity

83 Grade 1 or 2 fatigue, dryness of skin, anemia, and hypoalbuminemia were the mo

84 Dryness of the mouth and eyes results from involvement o

85 e patient (1.0%) treated with IB experienced dryness of the mouth, which resolved spontaneously.

86 starting around 4-5 months of age, with mild dryness of the tail accompanied by hair loss and inflamm

87 cations included trace haze (8%), epithelial dryness on day 1 (5%), interface inflammation secondary

88 Twenty-nine patients (66%) reported dryness on left side, 26 (59%) a Harlequin-type (unilate

89 by the interface and by symptoms of airways dryness (on a 10-point numerical rating scale), interfac

90 Thus, symptoms of dryness or pain can result from interferences with any p

91 ne disorder characterized by ocular and oral dryness or systemic manifestations.

92 e reactions during sex (P = .02) and vaginal dryness or tightness (P = .046).

93 more bone/muscle aches (P < .0001), vaginal dryness (P = .0004), and difficulty sleeping (P = .03).

94 84 in ocular discomfort (P = 0.0273) and eye dryness (P = 0.0291), the most common and severe symptom

95 unction, including decreased libido, vaginal dryness, pain with intercourse, decreased genital sensat

96 les (from 0 [best] to 10 [worst]) evaluating dryness, pain, and fatigue.

97 mmune disease characterized by mouth and eye dryness, pain, and fatigue.

98 eats and vaginal discharge, yet more vaginal dryness, painful intercourse, and loss of sexual interes

99 e common significant predictors were vaginal dryness, past chemotherapy use, and having a new partner

100 iva composition, rheological properties, and dryness perception and provide additional potential diag

101 h terrestrial CO(2) fluxes are controlled by dryness rather than temperature.

102 and finally the extract was concentrated to dryness, re-constituted with 1 mL methanol and determine

103 The final extracts are evaporated to dryness, redissolved in 10:90 or 20:80 acetonitrile/wate

104 Other symptoms were dryness, redness, burning sensation and itching.

105 Dryness resulting from exposure activates p38 MAPK signa

106 scein staining score >/=2.0 (0-4 scale), eye dryness score (EDS) >/=40 (0-100 visual analogue scale [

107 changes, -0.79 [-1.35 to -0.23]) and vaginal dryness score (pooled mean difference of changes, -0.26

108 -1.31 [95% CI, -2.02 to -0.61]) and vaginal dryness score (pooled mean difference of changes, -0.31

109 were change, from baseline to day 84, in eye dryness score (VAS, both eyes) and inferior corneal fluo

110 ly from the input variables: banana variety, dryness state and type and order of extract.

111 y eye symptoms, objective measures of ocular dryness, stimulated salivary flow; IgG, or ESR.

112 Corneal dryness stimulates production of certain MMPs in a strai

113 C) and their connections to increased global dryness (suppressed rainfall and reduced tropospheric re

114 than in areas in which both temperature and dryness (T < 16 degrees C) regulate plant productivity.

115 jects experienced greater improvement in eye dryness than placebo-treated subjects (treatment effect,

116 igation of the mouth with water to alleviate dryness, the cerebellum was less activated.

117 bitability conditions under extreme cold and dryness: the permafrost soil which is enriched in traits

118 s containing TDG and TDGO were evaporated to dryness under nitrogen, dissolved in organic solvent fol

119 leep disturbance at 6 months, and by vaginal dryness up to 60 months.

120 dry eye questionnaire (DEQ-5), rating of eye dryness using a visual analogue scale (VAS), and noninva

121 ng) and height with seasonal temperature and dryness variables in common garden experiments, suggesti

122 Urinary dryness was attained in 30 patients, usually by intermit

123 related both to the interface and to airways dryness was better with NHF (respectively, 2.6 +/- 2.2 v

124 r reported significant ocular irritation and dryness were analyzed.

125 nts of stimulated whole saliva flow and oral dryness were not significantly improved in the IFN alfa

126 tly the Southwest has experienced a spate of dryness, which presents a challenge to the sustainabilit

127 atient-reported symptoms of fatigue and oral dryness, with no significant improvement in the objectiv